New Hormone Discovery Offers Hope for Osteoporosis Treatment

CCN3, a potential new therapeutic hormone, holds promise to advance bone health treatment and improve quality of life for millions
New Hormone Discovery Offers Hope for Osteoporosis Treatment
Crevis/Shutterstock
|Updated:
0:00

Researchers have identified a new hormone, CCN3, that significantly strengthens bones. This discovery, made while studying how breastfeeding women maintain bone density, could transform the treatment of osteoporosis and bone fractures.

Published in Nature, the new study reveals that CCN3 promotes bone formation and repair in both male and female mice, offering new hope for millions of people suffering from bone-related conditions.

About the Study

Researchers at University of California–San Francisco (UCSF) and UC–Davis collaborated to solve a long-standing medical mystery: how breastfeeding women maintain strong bones despite the significant loss of calcium needed for milk production.
Sheramy Tsai
Sheramy Tsai
Author
Sheramy Tsai, BSN, RN, is a seasoned nurse with a decade-long writing career. An alum of Middlebury College and Johns Hopkins, Tsai combines her writing and nursing expertise to deliver impactful content. Living in Vermont, she balances her professional life with sustainable living and raising three children.
Related Topics